e-learning
resources
London 2016
Wednesday, 07.09.2016
From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD or not COPD: Answer in FEV1
Alicia Guillien (Besançon, France), Alicia Guillien, Marc Puyraveau, Thibaud Soumagne, Matthieu Veil-Picard, Pauline Roux, Stéphanie Guillou, Fabrice Rannou, Patrick Berger, Frédéric Mauny, Jean-Jacques Laplante, Jean-Charles Dalphin, Bruno Degano
Source:
International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease
Session:
From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease
Session type:
Poster Discussion
Number:
5034
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Alicia Guillien (Besançon, France), Alicia Guillien, Marc Puyraveau, Thibaud Soumagne, Matthieu Veil-Picard, Pauline Roux, Stéphanie Guillou, Fabrice Rannou, Patrick Berger, Frédéric Mauny, Jean-Jacques Laplante, Jean-Charles Dalphin, Bruno Degano. COPD or not COPD: Answer in FEV1. Eur Respir J 2016; 48: Suppl. 60, 5034
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Severity of airways obstruction and severity of COPD, which one?
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
Breathlessness perception in COPD: Relationship with exacerbation frequency
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
Mortality after COPD-exacerbations: Learning from epidemiology
Source: International Congress 2014 – Clinical presentations
Year: 2014
Annual FEV1 change : Post tuberculosis obstructive airway disease versus COPD
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and COPD subjects
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Lung function in never smoking patients with alpha1antitrypsin deficiency
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
Exercise capacity and lobar hyperinflation in patients with COPD
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013
Change in lung functions in patients with COPD during 6MWT
Source: Annual Congress 2013 –Clinical exercise physiology
Year: 2013
Heterogeneity in prevalence and underdiagnosis of COPD: Results from BOLD, EPI-SCAN, PLATINO, and PREPOCOL
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
Role of tuberculosis in COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Diabetes and hospitalization for COPD exacerbation
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
COPD in non-smokers: Report from the Tunisian burden of obstructive lung disease study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Survival in COPD patients with hospitalization due to exacerbation
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Small airway obstruction involvement in COPD severity
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Cardiovascular comorbidities of COPD in never-smokers
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014
COPD staging systems and BODE index
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016
Capnovolumetry as a cooperation free method in the diagnosis and monitoring of COPD
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Impulse-oscillometry (IOS) differences in asthma and COPD patients, and healthy-subjects
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept